StethoMe
StethoMe is a Poland-based medical device company that sells a digital auscultation stethoscope enabling home-based lung sound monitoring, targeting individual asthma patients through a direct-to-consumer model in its domestic market.
- Company typePrivate
- Founded2015
- HeadquartersPoznan, Poland
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What StethoMe does
StethoMe is a Poznan, Poland-based medical device company founded in 2015 that has developed the StethoMe® digital stethoscope, a consumer-facing auscultation device designed for home-based monitoring of respiratory sounds, with current positioning focused on asthma management. The company operates within the digital auscultation market, which leverages AI-powered analysis to interpret lung and heart sounds — a category forecast to reach $1.85 billion by 2030 at 15.7% CAGR. The product targets individual asthma patients who lack tools for continuous symptom monitoring between clinical visits, with the Polish-language website messaging "Kontroluj astmę ze StethoMe®" (Control your asthma with StethoMe) framing the value proposition around patient self-management.
The business model is direct-to-consumer hardware sales through the company's own e-commerce storefront (stethome.com), with revenue generated primarily through device sales to individual patients in a single domestic market. The company has accumulated approximately $7.9 million in disclosed funding across six rounds from 2015 through 2020, with investor participation from SpeedUp Venture Capital Group, TDJ Pitango Ventures, Manta Ray Ventures, Movens Capital, RST Ventures For Earth, and Google for Startups. Five co-founders remain in leadership roles — Wojciech Radomski (CEO), Paweł Elbanowski (COO), Jędrzej Kocinski (CSO & Head of Regulatory Affairs), Marcin Szajek (CTO), and Honorata Hafke-Dys (VP Product) — providing an unusual concentration of engineering, clinical science, and regulatory expertise for a company of its size (11–50 employees). The presence of a dedicated Head of Regulatory Affairs signals ongoing work on medical device certification pathways that would enable expansion beyond the current DTC model.
StethoMe firmographics
Firmographics- Name
- StethoMe
- Website
- https://StethoMe.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- StethoMe is a Poland-based medical device company that sells a digital auscultation stethoscope enabling home-based lung sound monitoring, targeting individual asthma patients through a direct-to-consumer model in its domestic market.
- Ownership category
- akta.pro rank
StethoMe industry classification
Industry- Product category
- Remote Patient Monitoring Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- SaMD – Monitoring, Triage & Risk Stratification Software (HLACANAE)
Keywords
Where StethoMe is headquartered
LocationHeadquarters
- HQ city
- Poznan
- HQ country
- Poland
- HQ region
- Europe
Markets served
StethoMe business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Revenue model
- Digital Health Device Sales: StethoMe generates revenue through the sale of its digital stethoscope hardware device designed for home asthma monitoring. Based on the direct-to-consumer positioning and digital health market patterns, the company likely combines hardware sales with potential ongoing subscription services for data analysis and monitoring.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
StethoMe product offering
Product offeringCore offering
StethoMe develops and sells the StethoMe® digital stethoscope, a hardware device combined with software that enables home-based digital auscultation of heart and lung sounds. The product is primarily marketed for asthma control and respiratory symptom monitoring, allowing patients to capture and analyze respiratory sounds from home between clinical visits.
Product overview
StethoMe® is a single core product offering focused on digital auscultation for asthma management. The product enables users to monitor and control their asthma through digital stethoscope technology.
Differentiator
Problem solved
Functional benefit
Products and services
- StethoMe® Digital Stethoscope A digital auscultation device (digital stethoscope) designed for home-based asthma control and respiratory symptom monitoring. It enables patients to capture lung sounds at home between clinical visits, with associated software/AI analysis supporting objective respiratory tracking and sharing of data with physicians. Target users are individual asthma patients and, indirectly, healthcare professionals using the captured data for remote auscultation.
Companies that use StethoMe
Customer profileSegments1 record
Ideal customer profiles2 records
StethoMe technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
StethoMe partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights5 records
StethoMe competitors and assessment
Company assessmentMarket position
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
StethoMe social profiles
Digital presenceStethoMe financial estimates
Financial estimateRevenue estimate
Valuation estimate
StethoMe leadership team
Management profileNumber of profiles
Profiles5 records
StethoMe funding detail
Funding detailFunding overview
Funding rounds6 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
StethoMe M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about StethoMe
What does StethoMe do?
StethoMe develops and sells the StethoMe® digital stethoscope, a hardware device combined with software that enables home-based digital auscultation of heart and lung sounds. The product is primarily marketed for asthma control and respiratory symptom monitoring, allowing patients to capture and analyze respiratory sounds from home between clinical visits.
Is StethoMe a public or private company?
StethoMe is a private company. It is classified as venture growth investor backed and is currently operating.
When was StethoMe founded?
StethoMe was founded in 2015. It employs 11 to 50 people.
Where is StethoMe based?
StethoMe is headquartered in Poznan, Poland, in the Europe region.
How does StethoMe make money?
One revenue line is on record: digital Health Device Sales.
Does StethoMe have an API?
No public API is recorded for StethoMe.
What industry is StethoMe in?
StethoMe's product category is Remote Patient Monitoring Devices. Its primary akta.pro industry code is HLACANAE, SaMD – Monitoring, Triage & Risk Stratification Software. Its NAICS code is 334510 and its SIC code is 3845.